Tag: Compass

COMPASS trial suggests that combination of rivaroxaban and aspirin lowers the...

By Hannah Woolley Findings from the Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease (COMPASS) trial suggest that the...
rivaroxaban

COMPASS study of Janssen’s rivaroxaban to end early for efficacy

The phase three COMPASS trial, evaluating the efficacy and safety of rivaroxaban (Xarelto, Janssen) for the prevention of major adverse cardiac events, including cardiovascular...